Imbrium Therapeutics

Imbrium is a clinical-stage biopharmaceutical company developing pharmacologic and biologic therapeutics.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: Stamford, Connecticut, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range: 11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded: 2018Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 1 supported appearance ↗Source: RevenueBase lists

The company at a glance

What does Imbrium Therapeutics do?

Imbrium is an operating subsidiary of Purdue Pharma L.P. and aims to develop and bring new medicines to market. Imbrium has a pipeline of investigational drug candidates and collaborates with industry and academic partners.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Oncology chemotherapeutics

Imbrium is pursuing oncology chemotherapeutics.

Source: LinkedIn company description · Retrieved October 13, 2026

Central nervous system treatments

Imbrium is pursuing treatments for disorders of the central nervous system.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#24OF 25

United States

Combination therapy developers

Snapshot: September 18, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Imbrium Therapeutics

#24 Combination therapy developers

Snapshot: September 18, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/combination-therapy-developers/united-states" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/imbriumthera/recognition-companies-combination-therapy-developers-united-states-20260919-1573c2e6fd950a801804db5e60c8ee16e48a8f0409961590d72f6b92fe3dce4e.svg" alt="Imbrium Therapeutics listed #24 on Combination therapy developers, September 18, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →